header logo image


Page 20«..10..19202122..3040..»

Archive for September, 2020

Pyrethrin Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type, Pest Types, Application – GlobeNewswire

Tuesday, September 15th, 2020

New York, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pyrethrin Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Pest Types, Application" - https://www.reportlinker.com/p05967903/?utm_source=GNW Pyrethrin is widely used in veterinary medicine for agricultural and domestic purposes. It is used for the treatment of ectoparasites in large and small animals and also in non-mammalian species such as birds, fish, and honeybees. It is used in veterinary medicine in various formulations, including spot-on, sprays, ear tags, soluble powders, and dips. Synthetic pyrethroids have been classified into two types, mainly type I and type II. It is observed that the addition of the alpha-cyano group to the 3-phenoxylbenzyl alcohol group in type II and increased the insecticidal potency. Pyrethrin and piperonyl butoxide together come in the form of a shampoo that is applied to the skin and hair. It is applied in two to three treatments to treat lice. Pyrethrin is also used in body lice medicines such as A-200, Pyrinate, Barc, Lice-Enz, Licetrol, Pronto, Tisit, Tisist blue and Tripple X. The medical application of Pyrethrin is yet another factor bolstering well the demand for pyrethrin all across the globe.

Based on pest type, the pyrethrin market has been segmented into mites, lepidoptera, coleoptera, coleoptera, diptera, and others.In 2019, the diptera dominated the market with the largest share.

The diptera or true flies include insects, such as midges, mosquitoes, sandflies, blowflies, and houseflies.The class of diptera flies contaminates the food and spreads diseases such as typhoid, malaria, and cholera.

The dipteran larvae are legless.They live in aquatic, semi-aquatic, or moist terrestrial environments.

Pyrethrin, as an insecticide, is highly capable of directly impacting the nervous system of diptera flies. This kills them directly or ends up harming their reproductive systems. Rise in adoption rate of pyrethrin as an insecticide due to its strong and life threatening effects on diptera has favored the global pyrethrin market.

In 2019, North America held the largest share of global pyrethrin market in 2019.Demand for pyrethrin in the region is expected to increase due to rise in requirement of hygiene products in the household sector.

Changing lifestyle, increase in population, and rise in disposable income of consumers favors the pyrethrin market in North America.Moreover, the high potency and effectiveness of pyrethrin as a vital ingredient in household and industrial sector also drives the market growth.

New investments and marketing strategies by manufacturers have also fueled the demand for pyrethrin in North America.Increase in cases of dengue fever and yellow fever have raised the need for pyrethrin in the region.

Inclination toward the use of organic products is yet another factor that favors the pyrethrin market in North America.

COVID-19 pandemic has been affecting economies and industries in various countries, including the US, Brazil, Russia, India, Italy, the UK, Iran, and Spain.Chemicals and materials is one the worlds major industries suffering serious disruptions in the form of supply chain breaks, event cancellations, and office shutdowns as a result of the lockdowns imposed in various countries to contain the disease spread.

China is the global manufacturing hub and largest raw material supplier for various industries; it is also one of the worst-affected countries by the COVID-19 pandemic.The lockdown of various plants and factories in China is affecting the global supply chains and adversely impacting the manufacturing and sales of various chemical and materials.

These factors are likely to restrain the growth of various markets related to the chemicals and materials industry in next few financial quarters.

A few key players present in the global pyrethrin market are Botanical Resources Australia Pty Ltd.; China Xian Nutrendhealth Biotechnology Co., Ltd.; Endura; Zhejiang Rayfull Chemicals Co., Ltd.; Pestech Australia Pty Ltd.; Scintex; Horizon Sopyrwa; Kapi Limited; and Zhengzhou Delong Chemical Co., Ltd; among others.

The overall global pyrethrin market size has been derived using both primary and secondary source.The research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information related to the pyrethrin market.

Also, multiple primary interviews were conducted with industry participants and commentators in order to validate data and analysis. The participants who typically take part in such a process include industry experts, such as VPs, business development managers, market intelligence managers, and national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders specializing in the pyrethrin market.Read the full report: https://www.reportlinker.com/p05967903/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See more here:
Pyrethrin Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Pest Types, Application - GlobeNewswire

Read More...

Veterinary Medicine Market is Thriving Worldwide 2020 | Trends, Growth and Profit Analysis, Forecast by 2027 – The Daily Chronicle

Tuesday, September 15th, 2020

New Jersey, United States, The Veterinary Medicine Market report 2020 provides a detailed impression, describe the product industry scope and the market expanded insights and forecasts up to 2027. It shows market data according to industry drivers, restraints and opportunities, analyzes the market status, the industry share, size, future Trends and growth rate of the market. The Veterinary Medicine Market report is categorized by application, end user, technology, product / service types, and other, as well as by region. In addition, the report includes the calculated expected CAGR of chitosan acetate-market derivative from the earlier records of the Veterinary Medicine Market, and current market trends, which are organized with future developments.

The Global Veterinary Medicine Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.

Download full PDF example copy of Veterinary Medicine Market report: (including Full Toc, list of tables and numbers, graph): https://www.verifiedmarketresearch.com/download-sample/?rid=21894&utm_source=TDC&utm_medium=001

Global Veterinary Medicine Market, By Product

OralInjectionOther

Global Veterinary Medicine Market, By Application

Companion AnimalsLivestock Animals

The report provides detailed coverage of the Veterinary Medicine Market, including structure, definitions, applications, and Industry Chain classifications. The Veterinary Medicine Market analysis is provided for the international markets including development trends, competitive landscape analysis, investment plan, business strategy, opportunities and development status of key regions. Development policies and plans are discussed and manufacturing processes and cost structures analyzed. This report also includes information on import / export consumption, supply and demand, costs, industry share, policy, Price, Sales and gross margins.

Ask For Discount @https://www.verifiedmarketresearch.com/ask-for-discount/?rid=21894&utm_source=TDC&utm_medium=001

Veterinary Medicine Market forecast up to 2027, with information such as company profiles, product picture and specification, capacity production, price, cost, revenue, and contact information. Upstream raw materials and equipment as well as downstream demand analyses are also carried out. The Veterinary Medicine Market size, development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and general research results are offered.

The Veterinary Medicine Market was created on the basis of an in-depth market analysis with contributions from industry experts. The report covers the growth prospects in the coming years and the discussion of the main providers.

To understand how the effects of COVID-19 are addressed in this report. A sample copy of the report is available at https://www.verifiedmarketresearch.com/product/Veterinary-Medicine-Market/?utm_source=TDC&utm_medium=001

Verified Market Researchis a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email:[emailprotected]

Read the original post:
Veterinary Medicine Market is Thriving Worldwide 2020 | Trends, Growth and Profit Analysis, Forecast by 2027 - The Daily Chronicle

Read More...

Crestview’s LaFever chosen by Ashland Elks as Teen of the Month – Richland Source

Tuesday, September 15th, 2020

ASHLAND -- Destiny LaFever has been named Ashland Elks Teen of the Month for September. Destiny is the daughter of Mark and Kristine LaFever and is a member of the Class of 2021 at Crestview High School.

LaFever is active in a variety of school activities including varsity soccer, basketball, softball choir and FFA. Her leadership positions include student council, National Honor Society, and FFA vice-president.

Outside of school, she is involved in 4-H. LaFever was the recipient of the 2020 Ashland County 4-H I Dare You award and the Market Steer Ultimate Exhibitor award. She enjoys showing market steers and market hogs at the Ashland County Fair as well as at the State Fair and Jackpot shows.

LaFever is employed at the Claremont Veterinary Clinic where she enjoys working with the animals and being able to help nurse them back to health.

After graduation, she plans to attend the Ohio State ATI campus for a year and then transfer to The Ohio State University main campus to major in animal science/ pre-veterinary medicine. She then hopes to attend The Ohio State University College of Veterinary Medicine and becoming the third generation veterinarian in her family.

The most important part of education comes from the support of those outside the classroom. Being informed is the first step. Your support does that for the entire community we share.

Read more:
Crestview's LaFever chosen by Ashland Elks as Teen of the Month - Richland Source

Read More...

Infectious diseases professor studies immune response – University of Georgia

Tuesday, September 15th, 2020

Vanessa Ezenwa, UGA Athletic Association Professor of Ecology, thinks bigand also really, really small.

A professor in the Odum School of Ecology and College of Veterinary Medicine department of infectious diseases, Ezenwas research integrates perspectives that range from the microbial to the ecosystem scale. Her work explores the ways that parasites influence the social behavior of large mammals and how that social behavior in turn influences parasite transmission. Her goal is to understand how those dynamics affect not only individuals but entire populations and communities of both parasites and hosts. And while she generally studies ungulates, her findings have implications for human health, as well.

Ezenwa, a recipient of a CAREER award from the National Science Foundation who came to UGA from the University of Montana in 2010, didnt set out to study the relationships between parasite transmission and social behavior in animals. As an undergraduate biology major at Rice University, her plan was to attend medical schooluntil, that is, she had the chance to work in a lab that focused on animal behavior.

Since high school I was quite interested in infectious diseases as related to medicine, but working in that lab got me interested in ecology and evolution, she said. Fast forward, I decided to go to graduate school to study animal behavior. I got introduced to the idea that how animals were socially organized, the types and size of groups they lived in and how fluid those dynamics were, that those things were associated with the transmission of parasites, and in turn that parasites actually drive the evolution of social organization in animals.

Ezenwa did her doctoral research at Princeton University on African ungulates in Kenya, where many species overlapped in the same locations. Her dissertation focused on 11 species that varied from living singly or in pairs to living in groups of 100 or more.

It really gave me the range of social types to look at, but at the same time I realized theyre all living together and theyre grouping together, as well. They often transmit the same parasites amongst one another and are infected by multiple parasite species simultaneously, she said. That has really shaped a lot of my research ever since.

A major theme of her current work is understanding the effects of coinfection by more than one parasite and/or pathogen on individuals and populations. In particular, she is investigating how the immune response to one pathogen influences the outcome of infection to another.

This work is inspired by a lot of work in humans, where for a long time people have been interested in the effect of parasitic wormsbecause theyre so common in humans in some parts of the worldon diseases caused by microbes like tuberculosis-causing bacteria and HIV, and what the connections are, she said. Ive been fascinated by the fact that we can try to understand these ideas and the underlying mechanisms, and also how they influence large-scale population level patterns of pathogen spread, in wildlife, potentially more easily than we could ever understand it in humans.

Ezenwas interest in exploring these questions from the microbial to the community level led her to develop the Infectious Disease Ecology Across Scales (IDEAS) doctoral training program. With funding from the National Science Foundation, the program introduces students to the study of infectious diseases from multiple scales and disciplinary perspectives.

Our goal is to train up-and-coming scientists studying infectious diseases to appreciate cross-scale linkages, said Ezenwa. And by cross-scale, its really different levels of biological organization, from the smallest to the largest, and realizing that all of these steps along the hierarchy actually matter.

See the rest here:
Infectious diseases professor studies immune response - University of Georgia

Read More...

Adtalem wagers on Walden University in hopes of building health-care education powerhouse – Inside Higher Ed

Tuesday, September 15th, 2020

Adtalem Global Education's plans to acquire Walden University, announced Friday, are part of an orchestrated push to become a national leader in health-care education.

Laureate Education will sell Walden University, a for-profit online institution that has for years stood out from Laureate's focus on emerging international markets, to Adtalem for $1.48billion. The transaction is expected to close mid-2021, pending regulatory approvals by the U.S. Department of Education and Walden's accreditor, the Higher Learning Commission.

Walden is one of the largest U.S. for-profit online institutions by student enrollment, according to federal data, following the University of Phoenix and Grand Canyon University -- although Grand Canyon disputes the U.S. Department of Education's decision to label it a for-profit for federal financial aid purposes.

Walden enrolls around 52,000 students, 78percent of whom are enrolled in health sciences programs, according to a university spokesperson. Walden offers more than 80 degree programs, mostly at the masters level, in areas such as education, business and public administration. It also offers programs leading to health-care professions such as nursing and mental health counseling.

Adtalem, formerly known as DeVry Education Group, sold online for-profit DeVry University to a small private company in 2017. The publicly traded company has amassed a significant portfolio of health care-focused institutions in recent years, including the American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and Chamberlain University, which bills itself as running the largest nursing school in the country across 22 campus locations.

The acquisition of Walden will ensure Adtalem is better positioned to increase the talent supply to address the rapidly growing and unmet demand for health care professionals in the U.S. and globally, the company said in a news release. Waldens program offerings and technology, its strong online capabilities, and its focus on diversifying the health care workforce are complimentary with Adtalems existing strengths as a leading health care workforce solutions provider and long track record of providing superior outcomes for students.

The combined institutions Adtalem will own will have 26 campuses in 15 states and four countries, the company said. They will have 6,100 faculty members and more than 90,000 students -- 34percent of whom are Black. The company claims it will be the world's top provider of M.D.s, Ph.D.s and nursing degrees to African Americans.

For Laureate Education, the sale marks a long-signaled departure from the U.S. higher education market. The publicly traded Baltimore-based company used to be well-known for its global campus network but sold off many of its international institutions to focus on the emerging higher education markets in South and Central America. Earlier this year, the company entered into a $642.7million agreement to sell three institutions in Australia and New Zealand to Strategic Education, the Minneapolis-based company behind Capella University and Strayer University.

Laureate Education has not been secretive about its desire to sell Walden. The company announced it was discussing a possible transaction with third parties in late 2018. In February 2019, the company said it had decided not to sell the university, stating that Laureate was best positioned to support Walden at that time. Then in January this year, Laureate indicated it was open to exploring "strategic alternatives for each of its businesses to unlock shareholder value" -- suggesting the university was again on the market.

The Walden acquisition is something Adtalem has desired for "some time," said Lisa Wardell, president and CEO of Adtalem, in an investor call on the deal last week. In the 12 months prior to June30, Walden University and associated company Walden e-Learning had approximately $591.3million in revenue and $146.5million in operating income, according to a recent U.S. Securities and Exchange Commission filing.

Whether anything will change at Walden University under Adtalems leadership is unclear. An Adtalem spokesperson said there will be no changes before the transaction is closed, and its too early to speculate beyond that time frame. In a letter to Walden University students, Ward Ulmer, the institutions president, said the sale does not change anything about your educational experience at Walden.

Both Walden and Adtalem have made it a priority that you continue to have the same strong academic programs and experience you have come to expect from our university, wrote Ulmer. The transfer of ownership does not affect your financial aid or Waldens TitleIV financial aid authorization. Walden will retain its current accreditations with the Higher Learning Commission, as well as all of its current programmatic and national accreditations. There will not be any changes in your curriculum or additional time to graduation due to the change in ownership.

Walden is expected to continue to be a stand-alone institution owned by Adtalem, according to Ulmer. It will keep the same name, and existing students will remain in their degree programs.

For Adtalem, selling DeVry and acquiring Walden is a reputational upgrade, said Trace Urdan, managing director at Tyton Partners, an investment bank and higher education consulting firm. Among for-profits, Walden has a good track record with regulators and is regarded as one of the most spotless actors in the sector, Urdan said.

Generally, investor interest in for-profit institutions has dwindled in recent years, but health care is the one place where people are still interested and investing, said Urdan. Walden has established online nursing programs and mental health programs that are not currently in Adtalems portfolio, he said.

Adtalem seems to be charging deeper into health-care education and going up the value chain, which makes a lot of sense, said Daniel Pianko, partner at University Ventures, a higher education investment firm.

Health-care education is tightly regulated by third parties and job opportunities are plentiful, he said. Some for-profit health-care education programs, particularly in nursing, are considered elite by employers. Demand for health-care professionals nationally is high, said Pianko. He said for-profit education seems to be more accepted in the U.S. for training health-care workers than it is in other fields.

The public sector hasnt been able to produce enough doctors and nurses for our society, especially during COVID, Pianko said. That makes it an area where it makes sense for for-profit institutions and private capital to operate.

While health-care education is a relatively respectable facet of for-profit education, there is a still a risk of increased regulation if a Democratic administration is elected this November, Urdan said. In purchasing Walden University using a mixture of cash on its balance sheet and additional debt, rather than equity, Adtalem is taking a risk, he said.

One of the truisms of managing through a hostile regulatory environment is that you want to have as much cash as possible on hand, Urdan said. This was the lesson of the demise of ITT and Corinthian. Those are both institutions that might still be in existence today if they hadnt spent all their cash.

As of June30, Adtalem had $500.5million in cash and cash equivalents, suggesting the company might need to borrow close to $1billion to close the deal with Walden. The company has also agreed to pay an $88million termination fee to Laureate if the acquisition cannot go through as a result of the imposition by the U.S. Department of Education of certain specified restrictions or if it fails to consummate the transaction upon satisfaction of the closing conditions.

That $88million termination fee is a pretty sizable bet that the U.S. Department of Education wont try to block the deal or require a letter of credit to secure continued access to federal financial aid, said Yan Cao, a fellow at the Century Foundation.

Adtalems acquisition of Walden is concerning to Cao. Under Laureates ownership, Walden was restricted from growing too quickly by regulatory controls imposed by the U.S. Department of Education.

The department imposed those controls because Laureate posted a financial responsibility composite score considered to be in the failing range for at least the last decade, Cao said. The regulatory controls may be lifted when the institution changes ownership, said Cao. Adtalem may have a better financial responsibility composite score than Laureate depending on the amount of debt it takes on, or the U.S. Department of Education might be convinced to consider the composite score of Walden University itself, rather than its parent company, when reviewing the transaction, said Cao.

Adtalems history of failed stewardship in managing DeVry University, an institution that racked up student complaints of fraudulent practices, should be of concern to regulators and Walden University stakeholders, said Cao.

DeVry in December 2016 agreed to pay $100million to settle a lawsuit brought by the Federal Trade Commission alleging the institution misled prospective students about its graduates' job-placement rates. The university denied any wrongdoing. Earlier that year, DeVry announced student protection reforms in response to criticism of the for-profit sector, including voluntarily capping the federal financial aid the institution receives from the U.S. Department of Education.

"DeVry is in the business of democratizing access to education, helping students achieve career goals and being a part of the solution to the workforce skills gap," said Wardell, then president and CEO of DeVry Education Group, in an interview with Inside Higher Ed at the time.

Read more:
Adtalem wagers on Walden University in hopes of building health-care education powerhouse - Inside Higher Ed

Read More...

How Are The Pandemic, Remote Work, Extreme Heat Affecting Our Furry Friends? – Texas Public Radio

Tuesday, September 15th, 2020

TUESDAY on "The Source" The COVID-19 crisis has changed and continues to affect everyday life, including for our pets and for the many animals still in need of a loving home.

More people are working remotely because of health concerns. How has this dynamic affected pet-owner relationships and what happens when it's time to return to the office?

Hurricane season and summer heat can also make life more stressful and dangerous for pets. What precautions should be taken? What should be done for a pet with heat-related illness?

How has the pandemic affected San Antonio animal shelters? What's happening with adoptions and fosters? What is the current level of need?What opportunities are there to volunteer?

What do we know now about whether animals can contract or spread COVID-19? Should owners be doing anything to protect their pets amid the pandemic?

Guests:

"The Source" is a live call-in program airing Mondays through Thursdays from 12-1 p.m. Leave a message before the program at(210) 615-8982. During the live show, call833-877-8255, emailthesource@tpr.org or tweet@TPRSource.

*This interview will be recorded on Tuesday, September 15.

More here:
How Are The Pandemic, Remote Work, Extreme Heat Affecting Our Furry Friends? - Texas Public Radio

Read More...

Tifton veterinary diagnostic lab pitches in with COVID-19 testing – The Albany Herald

Tuesday, September 15th, 2020

TIFTON In March, while the Tifton area was getting hit hard with COVID-19 cases, Dr. Jessica Beier, the medical director of Southwell Laboratories and Medical Director of Quality and Patient Safety, was quarantined at home after returning from a vacation in Chile.

When I got home, I was ready to activate, Beier said. While I was gone, we had used the CDC lab, the state lab, our usual reference lab, and all those labs were becoming overwhelmed. Their turnaround times were starting to increase, and we were looking at people potentially having to wait a week to know whether they had tested positive for COVID-19. Everyone was wondering what we were going to do next, and then I was told by our employee health director that I had traveled to a country that was considered a level three risk.

I was quarantined at home, and it was really not a good time. I brought my microscope and started doing pathology from home. In the midst of all of this, I had a lot of time on my hands to think, and because I have a horse farm, I am well aware that we have a vet diagnostic lab here in Tifton thats part of UGA. I also know that this lab here does high-complexity molecular diagnostic testing because of all of the infectious disease testing they normally do on animals.

Something clicked in Beiers head. Why not partner with UGA and the lab that was right in her own backyard to meet the pandemic head on? Although she had no contacts with anyone at the diagnostic lab, she was able to find the email address for Hemant Naikare, Tifton Veterinary Diagnostic and Investigational Lab director and am associate professor of infectious diseases in the College of Veterinary Medicine and reached out to him.

I remember Dr. Beier reaching out to me on a Saturday at the end of March, Naikare said. She wanted to know if we could assist with COVID testing, so we started correspondence the first week of April. I told her that we had the infrastructure, and we do polymerase chain reaction (PCR) testing, which is an essential component of processing COVID-19 tests. I explained to her that we could help, but our major hurdle was CLIA.

CLIA stands for Clinical Laboratory Improvement Amendments, and for labs to process human samples, they must be registered and certified under CLIA.

One aspect of the UGA College of Veterinary Medicine and TVDILs mission is service to the state. Usually, that means aiding local livestock producers, veterinarians, or companion animal owners in south Georgia but the pandemic provided a unique situation.

I knew that these long turnaround times were a huge problem, especially here in rural Georgia, so I took this issue to my department head, Dr. Jesse Hostetter, and CVM Dean Lisa Nolan, Naikare said. Dr. Beier and Southwell were in need of support, and it was clear to me that we could help. I explained that we had the equipment needed for human testing, and we had the trained personnel. It was just a matter of getting started. With the permission and the right credentials, we could definitely help out.

The TVDIL is able to run an average of about 125 COVID-19 tests per day, many of which are sent over from Southwells drive-thru testing site, and these are processed usually within 24 hours. Most inpatients at Tift Regional Medical Center who need to be tested use a rapid test that is processed through the in-house laboratory there.

Success! An email has been sent to with a link to confirm list signup.

Error! There was an error processing your request.

We can run up to 270 tests per day without impacting our mission of animal testing, Naikare said. Just within the last four weeks, the TVDIL has conducted over 3,000 tests for hospitalized patients, pre-surgical patients, symptomatic patients, potentially exposed individuals, and patients and staff from various healthcare settings. Dr. Yung-Yi Mosley, an assistant professor of infectious diseases in the College of Veterinary Medicine has been instrumental in getting the high-volume COVID-19 PCR testing workflow streamlined at the TVDIL lab.

While the TVDIL was originally testing only samples from Southwell, its staff has also partnered with two other local hospital systems recently: Crisp Regional Health System in Cordele and Colquitt Regional Medical Center in Moultrie.

COVID-19 molecular testing is still in high demand, so we hope to ease the burden on other testing labs in the region by providing rapid and accurate test results, Naikare said. By helping these local health systems attain a quick turnaround testing, we are able to prevent community spread in rural Georgia.

While some veterinary diagnostic labs have pivoted to test human samples and help with turnaround times for COVID-19 testing, it is still a fraction of the laboratories in the country. According to Naikare, who estimates there are at least 65 state or university veterinary diagnostic labs in the country, as of Aug. 7, there were only 18 labs that were testing human samples.

We felt that we could really contribute to human testing, and so we are ahead of the curve, Naikare said. At UGA, One Health is the term used to describe the intersection of human, animal, and environmental health. We are providing diagnostic solutions, and this is One Health in action.

I feel very lucky that we happened to be in the right town with the right lab and the right people to make this happen, Beier said. This has taken a lot of teamwork from everyone involved, and I think this shows how much people care about their community to work together and collaborate like this in a crisis. I am so grateful to all my staff at the TRMC lab who have helped to make this partnership work, and all of us at Southwell are grateful to Dr. Naikare and his entire team for everything they have done and continue to do.

Southwell is a leading health care provider serving 12 counties in south-central Georgia. Tift Regional Medical Center, the flagship hospital, is a 181-bed regional referral center offering signature services in surgery, oncology, cardiovascular care, womens health and more. Southwell comprises TRMC and the TRMC West Campus in Tifton, Southwell Medical Hospital and Southwell Health and Rehabilitation in Adel and more than 30 primary care and specialty clinics located throughout the region. Visit http://www.tiftregional.com for more information.

The UGA College of Veterinary Medicine, founded in 1946, is dedicated to training future veterinarians, conducting research related to animal and human diseases, and to providing veterinary services for animals and their owners. Research efforts are aimed at enhancing the quality of life for animals and people, improving the productivity of poultry and livestock, and preserving a healthy interface between wildlife and people in the environment they share. In addition to the DVM program, the college offers masters, Ph.D., and dual-degree programs for students who want to pursue a career in veterinary medicine or a related field, including public health and biomedical research.

Read more:
Tifton veterinary diagnostic lab pitches in with COVID-19 testing - The Albany Herald

Read More...

Global Veterinary Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 – Verdant News

Tuesday, September 15th, 2020

Global Veterinary Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 carries out an extensive market analysis covering market aspects like market trends, growth drivers, constraints, and challenges existing in the market. The report aims to define, describe, and forecast the global Veterinary Medicine market in terms of type, application, and region. The report offers an industry-wide competitive analysis, market segments analysis, individual market share of leading players, and the contemporary market scenario. The most vital elements necessary for analyzing this market are included in the report. The key regions (countries) promising a huge market share for the forecast period are covered in the report. The report gives a precise analysis of market size, trends, share, production, and futuristic developments trends, and present and future market status, and forecast, the outlook from 2020 to 2026.

Market Analysis:

The report explores key regions market potential and advantages, opportunities and challenges, restraints, and risks that key players facing in this industry. The report covers the prominent players in the global Veterinary Medicine market with detailed SWOT analysis, financial overview, and key developments. Other information like company profiles, product picture, and specifications, sales revenue, price, gross margin, market share has also been included. The market report is extensively categorized into different product types, applications, player, and regions. The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for this sector.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/17516

Essential vendors involved in this report are: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group, Parnell

In terms of geography, the global Veterinary Medicine market includes regions such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

With the list of tables and figures, the report provides key statistics on the condition of the business. The research covers the business overview, market segment, upstream, downstream analysis. The report sheds light on the recent developments and innovations in the market as well as several strategies such as the PESTEL analysis and SWOT analysis. The study report covers all the geographical regions where the competitive landscape exists. Thus global Veterinary Medicine market report helps to identify the key growth countries and regions.

Based on type, the market has been segmented into: Oral, Injection, Other

Based on application, the market has been segmented into: Companion Animals, Livestock Animals

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/17516/global-veterinary-medicine-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2026

Key Factors Involved In the Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

See more here:
Global Veterinary Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 - Verdant News

Read More...

Weekend reads: Can you catch the coronavirus from your pet? Probably not, experts say. – The Daily Briefing

Tuesday, September 15th, 2020

September 11, 2020 Ben Palmer's reads

How will the coronavirus pandemic end? The coronavirus pandemic may be the first pandemic to hit the United States in more than century, but it's far from the first pandemic the world has ever faced. Writing for ABC News, Tegan Taylor looks back at past, similar pandemics, including the 1918 Spanish Flu and the 2009 Swine Flu pandemic, and details how those pandemics came to an endand what they might mean for the current coronavirus crisis.

Why do Americans go to the gym? Americans are flocking back to gyms as the facilities begin to reopen, even as the novel coronavirus remains a threat. Writing for The Atlantic, Amanda Mull looks at why Americans prefer going to the gym as opposed to working out at home, what role the gym plays in American culture, and how physical activity has changed over the past 70 years, evolving from a necessity to a leisure activity.

Can you catch the coronavirus from your dog? Since the coronavirus pandemic first began, the World Organization for Animal Health has recorded at least 20 cases of the virus among individual animals, as well as some outbreaks among groups of animals living in close proximity to each other, the Wall Street Journal's Jason Douglas reports. According to Douglas, public health officials in nearly every case confirmed that the animals had contracted the coronavirus from a human who was infected, and there currently are no recorded cases of animals transmitting the coronavirus to people. Jenny Stavisky, an assistant professor in veterinary medicine and science at the University of Nottingham in England, told Douglas that current evidence suggests humans are unlikely to contract the virus from their pets. "The main message here is that even if pets get it they are unlikely to get sick, and there is so far no evidence that an infected pet can go on and infect a human," she said.

Muscular mice may help scientists unlock the key to preventing muscle and bone lossin space. When astronauts travel to space, they exercise two hours per day to slow down muscle and bone less, NPR's John Hamilton reports. But a study published Tuesday in the journalProceedings of the National Academy of Sciences suggests mice may offer clues on how to preserve muscle and bone mass in people, including those who are on interplanetary journeys. For the study, researchers gave mice that spent a month on the International Space Station a drug that neutralized two naturally occurring substances in micemyostatin and activin Athat typically limit muscle and bone growth. Se-Jin Lee, a professor at The Jackson Laboratory and the University of Connecticut who was involved in the study, said the researchers found "[t]he drug was effective not just in preserving the muscle mass and bone mass, but actually caused the muscles and bones to grow." Based on those findings, the researchers are hopeful that the drug may also help protect astronauts against muscle and bone lossand perhaps even people with weak muscles or easily fractured bones.

See the original post:
Weekend reads: Can you catch the coronavirus from your pet? Probably not, experts say. - The Daily Briefing

Read More...

Live a life free of neuropathy – KHOU.com

Tuesday, September 15th, 2020

Stop the debilitating symptoms of neuropathy with help from Advanced Nerve and Health Center

HOUSTON Call Advanced Nerve and Health Center now at 832-626-1260 or log on to NerveAndHealth.com.

The Advanced Nerve and Health Center has a limited time offer for Great Day Houston viewers. For $29, get a tele-health visit, an in-office consultation, a copy of Dr. Thai's "Healthy Diet to Heal Nerve Pain" book, and a diagnostic nerve test to see if they can help. This is a $249 value.

Advanced Nerve and Health Center is located at 8558 Katy Freeway, Suite 116, Houston, TX 77024.

The Advanced Nerve and Health Center treats the root cause of neuropathy and reverses the damage to the nerve. Dr. Bao Thai and Dr. Aliena Sohail shared more in the video above about their process and how it works. Patient Anna Hernandez is extremely happy with the results. As a restaurant owner, she is on her feet all day long. The pain used to be so extreme, she couldn't walk a block without pain. After treatments, she's noticed significant change and is now able to walk longer distances. It has been life changing for her. She is very thankful for the nurturing and comforting nature of the staff at Advanced Nerve & Health Center.

This content sponsored by Advanced Nerve and Health Center.

Read more from the original source:
Live a life free of neuropathy - KHOU.com

Read More...

Comprehensive Report on Diabetic Peripheral Neuropathy Treatment Market by global COVID-19 impact analysis, industry trends, business strategies,…

Tuesday, September 15th, 2020

Report Ocean recently published Diabetic Peripheral Neuropathy Treatment Market report which highlights the important factors that are expected to shape the growth of the Diabetic Peripheral Neuropathy Treatment Market over the forecast period. The current trends, market drivers, opportunities, and restraints are thoroughly evaluated to provide a clear understanding of the current market landscape of the Diabetic Peripheral Neuropathy Treatment Market. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porters Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Diabetic Peripheral Neuropathy Treatment Market.

The COVID-19 (Coronavirus) outbreak has led to both advantages and disadvantages for companies in the Diabetic Peripheral Neuropathy Treatment Market. With the help of our recently published report, market players can adopt innovative strategies to overcome the challenges that lie ahead of the COVID-19 lockdown period. Through our research study, companies can gain factual information about COVID-19 and how its impacting the sales of products in the global market landscape.

Request Free Sample Report athttps://reportocean.com/industry-verticals/sample-request?report_id=mai50223

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain in the Diabetic Peripheral Neuropathy Treatment Market. The report Diabetic Peripheral Neuropathy Treatment Market provide in-depth analysis of current market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on Diabetic Peripheral Neuropathy Treatment Market segments and geographies.

This Diabetic Peripheral Neuropathy Treatment Market report begins with a basic overview of the market. The analysis highlights the opportunity and Diabetic Peripheral Neuropathy Treatment Market trends that are impacted the market. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Diabetic Peripheral Neuropathy Treatment Market insight regarding the things which are driving and affecting the earnings of the market.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Market Data Breakdown by Key Geography, Type & Application / End-User

By type (past and forecast)

Diabetic Peripheral Neuropathy Treatment Market: Specific Applications Sales and Growth Rates (Historical & Forecast)

Diabetic Peripheral Neuropathy Treatment Market revenue and growth rate by the market (history and forecast)

Diabetic Peripheral Neuropathy Treatment Market size and growth rate, application and type (past and forecast)

Competitive Landscape:Key players in the global Diabetic Peripheral Neuropathy Treatment market covered in Chapter 4:Reata Pharmaceuticals IncKPI Therapeutics IncAchelios Therapeutics IncViroMed Co LtdNovaremed LtdCommence Bio IncGrunenthal GmbHImmune Pharmaceuticals IncMitsubishi Tanabe Pharma CorpMedifron DBT Co LtdRelief Therapeutics Holding AGDiabetic Peripheral Neuropathy Treatment Market competitive landscape provides details and data information by major players. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetic Peripheral Neuropathy Treatment Market business, the date to enter into the Diabetic Peripheral Neuropathy Treatment Market, product introduction, recent developments, etc.

Market Segmentation:

The segmentation is used to decide the target market into smaller sections or segments like product type, application, and geographical regions to optimize marketing strategies, advertising technique and global as well as regional sales efforts of Diabetic Peripheral Neuropathy Treatment Market.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India, Middle East and Africa and Central and South America.

Study objectives of Diabetic Peripheral Neuropathy Treatment Market Report:

To provide economic factors, technology trends, and market trends that influence the global Diabetic Peripheral Neuropathy Treatment Market growth

To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries

To provide historical, current, and forecast revenue of market segments based on material, type, design, and end-user

To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global Diabetic Peripheral Neuropathy Treatment Market

To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market

Inquire or Share Your Questions If Any before Purchasing This Report:https://reportocean.com/industry-verticals/sample-request?report_id=mai50223

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, and Asia.

Contact Us: +1 888 212 3539 (US) +91-9997112116 (Outside US)Contact Person: Matthew SEmail:[emailprotected]

See more here:
Comprehensive Report on Diabetic Peripheral Neuropathy Treatment Market by global COVID-19 impact analysis, industry trends, business strategies,...

Read More...

Sales Of To Compel The Neuropathic Pain Market To Reach In 2024 – Scientect

Tuesday, September 15th, 2020

Market Size US$ 10,414.0 Mnin 2024, Market Growth CAGR of 5.6%, Market Trends Growing prevalence ofHealthcare Industry

Reaching the revenues of over US$ 6 Bn at the end of 2019, the globalneuropathic pain management marketis projected for a healthy CAGR during the forecast period (2019 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.

Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/4149

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4149

Key Takeaways Neuropathic Pain Management Market Study

Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.

Increasing R&D Spending by Pharmaceuticals Companies Shaping Future

One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/4149

At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.

What Does the Report Cover?

The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 2018 and presents demand projections during 2019 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRIs, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Follow this link:
Sales Of To Compel The Neuropathic Pain Market To Reach In 2024 - Scientect

Read More...

Waldenstrm Macroglobulinemia Treated With Ixazomib Combination Therapy: Long-Term Follow Up – Hematology Advisor

Tuesday, September 15th, 2020

The combination of the ixazomib, dexamethasone, and rituximab (IDR) yields durable responses and maintains an excellent safety profile in patients with Waldenstrm macroglobulinemia (WM), according to results of a study published in Blood Advances.

The investigators elected to assess IDR due to the favorable safety profile of ixazomib, in particular a low incidence of neuropathy, in multiple myeloma.

The long-term follow-up results included all 26 treatment-naive patients with WM who participated in the prospective, phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT02400437) that evaluated the combination of IDR.

For the study, IDR was administered over 12 cycles: six 4-week induction cycles followed by six 8-week maintenance cycles.

All patients had the MYD88 L265P mutation, and CXCR4 mutations were present in 15 patients (58%). The median age at treatment initiation was 65 years (range, 46-82 years).

The median time to response was 2 months, and the median time to major response was 6 months. CXCR4 mutation status appeared to have an effect on the time to response; patients with CXCR4 mutations had a longer median time to response than those without mutations (3 months vs 1 month, respectively; P =.003). However, no significant difference was observed in the median time to major response between the genotypes (10 months vs 3 months, respectively; P =.31).

IDR induced high rates of response among the cohort. The overall response rate was 96% (95% CI, 80-100) while the major response rate was 77% (95% CI, 56-91). At best response, 19% of patients achieved a very good partial response (VGPR), 58% achieved a partial response, 19% had a minor response, and 4% had stable disease. The rate of VGPR was higher in patients without CXCR4 mutations than in patients with CXCR4 mutations (36% vs 7%; P =.06).

Among all patients, the median progression-free survival and median duration of response (DOR) was 40 months and 38 months, respectively. The median time to next treatment was also 40 months. None of these outcomes were associated with CXCR4 mutational status.

The safety profile was considered excellent, although some patients experienced grade 3 adverse events, which included infections (2 patients, unrelated to treatment), hyperglycemia (2 patients, from dexamethasone), infusion reactions (2 patients, with rituximab), and neuropathy (1 patients, due to uncontrolled diabetes). No grade 4 adverse events or deaths occurred.

The authors concluded, On the basis of the findings of our study, IDR represents an easy-to-administer, safe, and effective treatment option for patients with WM, with high rates of durable responses and an excellent adverse event profile.

Disclosures: Some authors have declared affiliations with or received funding from the pharmaceutical industry. Please refer to the original study for a full list of disclosures.

Castillo JJ, Meid K, Flynn CA, et al. Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenstrm macroglobulinemia: long-term follow-up. Blood Adv. 2020;4(16):3952-3959. doi:10.1182/bloodadvances.2020001963

Continue reading here:
Waldenstrm Macroglobulinemia Treated With Ixazomib Combination Therapy: Long-Term Follow Up - Hematology Advisor

Read More...

Chemotherapy Induced Peripheral Neuropathy Market Set To Register A CAGR Growth Of XX% Over The Forecast Period 2019 2029 – Daily Research Chronicle

Tuesday, September 15th, 2020

In this report, the global Chemotherapy Induced Peripheral Neuropathy market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025.

Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Chemotherapy Induced Peripheral Neuropathy market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Chemotherapy Induced Peripheral Neuropathy market. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Chemotherapy Induced Peripheral Neuropathy market to assist our clients arrive at beneficial business decisions.

The Chemotherapy Induced Peripheral Neuropathy market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the Chemotherapy Induced Peripheral Neuropathy market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/30209

Resourceful insights enclosed in the report:

The major players profiled in this Chemotherapy Induced Peripheral Neuropathy market report include:

key players and product offerings

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/30209

The market report addresses the following queries related to the Chemotherapy Induced Peripheral Neuropathy market:

The study objectives of Chemotherapy Induced Peripheral Neuropathy Market Report are:

To analyze and research the Chemotherapy Induced Peripheral Neuropathy market status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the Chemotherapy Induced Peripheral Neuropathy manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions Chemotherapy Induced Peripheral Neuropathy market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Chemotherapy Induced Peripheral Neuropathy market.

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/30209

Read more:
Chemotherapy Induced Peripheral Neuropathy Market Set To Register A CAGR Growth Of XX% Over The Forecast Period 2019 2029 - Daily Research Chronicle

Read More...

ANALYSIS – Effect of global warming and environmental temperature on human health and lifestyle – Anadolu Agency

Tuesday, September 15th, 2020

*The Iranian writer holds a PhD in Genetics, Molecular Biology and Epigenetic and works at the Genetics Department of the University of Malayas Faculty of Science.

KUALA LUMPUR

The Intergovernmental Panel on Climate Change (IPCC) is the UN body for assessing the science related to climate change. IPCC officially released a critical report in 2014 that addressed the impact of global warming on living phenomena on Earth [1]. In 2015 the UN Climate Change Conference, held in Paris, aimed to achieve a legally binding and universal agreement on curbing the effects of climate change. Leaders of 150 nations, along with 40 thousand delegates from 195 countries attended 2015 UN Climate Change Conference in order to tackle climate change on a global political level.

Climate change in the Middle East area is an issue taking on a greater and greater intensity. Middle East countries, especially Iran, will be experiencing an increase of 2.6 degrees C in mean temperatures in the following decades.

It is predicted that the environmental temperature will increase substantially in Southeast Anatolia and the coastal areas of the Mediterranean region, including Iran [2] and Turkey by the end of the 21st century [3]. Iran has been a member of the United Nations Framework Convention on Climate Change (UNFCCC) since 1992 and Turkey became a member in 2004 [4]. Even though both countries are members of the UNFCCC and despite the critical climate situation warnings regarding these regions, the lack of high-quality data and information, the insufficiency of scientific research as well as risk management of natural resources, and the current level of attention given to the profound relationship between human health and climate change are alarming.

The environmental temperature might have fluctuating impacts on many creatures throughout their lives, including humans. This effect may occur yearly, seasonally, or daily, and usually does not remain constant. There is a question to ponder on; how does an organism struggle with long-term or severe temperature changes? [5] Heat exposure will cause a broad range of negative results for human beings, which will start with an unpleasant sensation, continue with decreasing performance in physical activities and cognitive faculties, followed by a number of cardiovascular and respiratory symptoms that will lead to diseases in addition to an increasing number of hyperthermia- and hypothermia-related and heatstroke deaths, all of which mean higher mortality.

Cardiovascular, respiratory and trauma deaths have been reported to increase in extreme temperatures in Iran. It was also reported that diseases like malaria, leishmaniasis and cholera may change pattern and appear in provinces where they were not prevalent before. [2]

Recently, the increasing frequency of extreme weather events due to climate change has shown parallels with morbidity in certain sections of societies. There is a need to identify vulnerable populations. The adverse health effects are often preventable with relatively simple measures; therefore, factors such as age, gender, fitness, subcutaneous fat, shape and form, health, medication, adaptation will affect the heat balance. The development of management at the initial steps of the vulnerability will improve the function and working ability and reduce healthcare costs.

It was estimated that, without accounting for harvesting activities, summer heat accounted for the loss of approximately 23,000 years of life per year during the 1990s. During these years, 55 % of life lost was among individuals younger than 75. A trial study confirmed that mortality displacement was applied in society for 30 days; the overall impact was reduced by 75% on the average count. Harvesting was more pronounced in North-continental cities than in Mediterranean cities and was stronger among young people than among the elderly. [6].

The estimate of the threshold during the period evaluated was 29.4 degrees C for Mediterranean cities and 23.3 degrees C for North continental cities. It was estimated that only a 1-degree C increase in maximum apparent temperature above the Mediterranean cities threshold was 3.12%, and for North continental cities 1.84%. The highest mortality rate was seen in elderly people and due to respiratory diseases, demonstrating that the segment of the population most vulnerable to heat were elderly people. Subsequently, those with chronic diseases, children, women above 65 years of age, and people adapted to cold climates had serious difficulties coping with heat, and overall they were considered a vulnerable population.

Socioeconomic factors such as social isolation, air-conditioning usage, exceptional situations (such as long electricity blackouts), and lack of experience in dealing with the new environmental conditions are considered as other factors that increase the mortality rates in these areas. In critical circumstances, individuals taking appropriate approaches towards heat are essential. In healthy people in the population, the amount of exposure to heat, exercise, clothing (i.e. use of textile materials with good moisture transfer qualities), nutrition and hydration are essential. In the at-risk population, right adjustment of medication, treatment, proper behavior in crisis are very important. Lastly, there are discussions on organization management in terms of changing the workplace rules for reducing the time individuals are exposed to heat. In conclusion, human lifestyle plays a vital role in coping with climate change and heat exposure [7].

Effect of global warming and environmental temperature on human enzymatic activity and disease rate

The impact of climate change has been significantly threatening human health based on different parameters. Temperature is a dangerous abiotic factor that affects organisms on an ecological level through infiltrating their molecular and cellular structures. Temperature (heat-cold) is a measure of the kinetic energy of the molecules in a system. Environmental temperature has a direct effect on the molecular response and enzymatic activity of animals and subsequently has a direct impact on the rate of the disease.

At this stage, a question arises: what other mechanisms might be affected in response to thermal stress? An additional serious question also suggests itself: what effects does temperature have on enzymatic activity?

Enzymes are protein molecules activated in their tertiary structure. An enzyme may become inactive by an inhibitor or under adverse thermal circumstances. The enzyme activity would reach its highest range in the optimum thermal condition and will decrease in high temperature due to denaturation.

All enzymes have a range of temperatures for their activities. In eukaryotes, the enzymes have an optimum temperature that is the best reaction for their optimum enzymatic activity, which in humans is around 37 degrees (98.6F), the average body temperature. Enzymes activity has an interdependent interaction with high temperatures [8]. All animals have the capacity to adapt to the environmental temperature, albeit in limited scopes. In order to survive, animals from hot climates such as deserts and tropical climates adapt their enzymatic activity to the highest optimum range.

In contrast, animals from cold weather adapt their enzymatic activity to the lowest optimum range [9]. Even though the animals have this adaptation capacity to the temperature limits, there is still a limited tolerance range for their enzymatic activity and survival [10]. These limited ranges are the two ends of the enzyme activity. Enzymes are proteins, and they will break down at temperatures above 40 degrees Celsius (104 F) [11].

Most animal enzymes will lose their activity above 40 degrees C. In high temperatures, the active site of the enzyme will be denatured and lose its 3D structure. The temperature, therefore, has a strong effect on enzyme activity [11]. And the deficiency in enzymatic activity due to heat caused by climate changes will subsequently cause respiratory diseases, cardiovascular diseases, mental health problems [12, 13], and different types of cancer [14].

Conclusion

Even though the IPCC reports addressing the impacts of global warming on Earth were officially released in 2014, the effect of temperature on human health has since remained largely neglected. It is clear that the environmental temperature has a direct impact on the body temperature and, subsequently, on the enzymatic activity as an environmental stressor. All beings, including human beings, are threatened by the fluctuations in environmental temperature caused by global warming. It has become critical to determine the scope of scientific research on climate change and the associated animals and human health impact. So, to the authors point of view, such studies that report on human health and environment interaction under different climate circumstances contribute to generating more insights into the impacts weather and temperature have on human health.

**Opinions expressed in this article are the authors own and do not necessarily reflect the editorial policy of Anadolu Agency.

References:

[1] Pachauri, R.K., et al., Climate change 2014: synthesis report. Contribution of Working Groups I, II and III to the fifth assessment report of the Intergovernmental Panel on Climate Change. 2014: Ipcc.

[2] Khanjani, N., The Effects of Climate Change on Human Health in Iran Public Health Review, 2016. 3(1).

[3] R, I.O.E.U.T., Turkeys National Climate Change Adaptation Strategy and Action Plan. , 2011.

[4] Wikipedia, List of parties to the United Nations Framework Convention on Climate Change.

[5] Hochachka, P. and G. Somero, Biochemical adaptation: mechanism and process in physiological evolution. 2002: Oxford University Press.

[6] Michela Baccini, et al., Heat Effects on Mortality in 15 European Cities. Epidemiology, 2008. 19: p. 711-9.

[7] MIkheimo, T., The effects of temperature on human health. Institute of Health Sciences, University of Oulu, 2013.

[8] Rodrigues, R.C., et al., Modifying enzyme activity and selectivity by immobilization. 2013. 42(15): p. 6290-6307.

[9] Bilal, M. and H.M.J.I.j.o.b.m. Iqbal, Naturally-derived biopolymers: Potential platforms for enzyme immobilization. 2019.

[10] Jiang, W., et al., Effects of temperature change on physiological and biochemical responses of Yesso scallop, Patinopecten yessoensis. Aquaculture, 2016. 451: p. 463-472.

[11] Wei, Y., et al., Improved lignocellulose-degrading performance during straw composting from diverse sources with actinomycetes inoculation by regulating the key enzyme activities. 2019. 271: p. 66-74.

[12] Ito, K., S.F. De Leon, and M.J.E. Lippmann, Associations between ozone and daily mortality: analysis and meta-analysis. 2005: p. 446-457.

[13] Page, L.A. and L.J.P.M. Howard, The impact of climate change on mental health (but will mental health be discussed at Copenhagen?). 2010. 40(2): p. 177-180.

[14] Seyfried, T.N.J.F.i.c. and d. biology, Cancer as a mitochondrial metabolic disease. 2015. 3: p. 43.

More:
ANALYSIS - Effect of global warming and environmental temperature on human health and lifestyle - Anadolu Agency

Read More...

Community remembers longtime Floyd Central teacher Ray Weatherholt – Evening News and Tribune

Tuesday, September 15th, 2020

FLOYD COUNTY The community is remembering the legacy of Ray Weatherholt, a beloved high school teacher who sparked a love for learning and science in many students over the years.

Weatherholt, a retired science educator who taught for 36 years at Floyd Central High School, died Tuesday at age 80. He was known for his passion for nature and gardening, and he was involved in organizations such as the Floyd County Purdue Extensions Sunnyside Master Gardeners program.

Weatherholt taught at Georgetown High School from 1964 to 1966, and he started teaching at Floyd Central High School when it opened in 1967. He retired from Floyd Central in 2002.

At Floyd Central, he helped establish rigorous science classes such as anatomy, microbiology and botany, and he was inducted into the schools Hall of Fame in 2016.

Dr. Rex Bickers, a retired neonatologist, attended Weatherholts biology class the year Floyd Central opened, and the teacher quickly became his mentor. He received an advanced education as Weatherholts student, and he was not challenged like that again until medical school, he said.

What I got out of 10th grade biology class was a transition into medical school biochemistry class thats no joke, he said.

Although Weatherholt was only 13 years older than Bickers, he became like a second father to him. They have been good friends over the past 20 years. They often talked, got together or emailed each other, and they enjoyed sending each other science news.

In a tribute posted on Facebook, Bickers reflected on the loss of his friend and former teacher.

For now, the smile of that extraordinary man has disappeared, those hands, that heart the size of Mammoth Cave, he wrote. But I will stop breathing before Ray Weatherholt leaves my brainand all the buzzing molecules that keep him alive there.

Lee Schmidt, a 1999 Floyd Central grad, said Weatherholt was a major reason he became a scientist. He went on to receive a doctorate in biochemistry and molecular genetics.

Weatherholt was a quiet, gentle man who loved biology, life and learning, Schmidt said, and he was a teacher who never stopped learning.

In his classes, students learned from college textbooks, and students were encouraged to challenge themselves through science experiments. Schmidt said Weatherholt taught him the art of failing, a life lesson that has been valuable in his work as a scientist and researcher.

He said if I dont fail early, fail often, Im not pushing myself that was one of my favorites, he said. Dont be scared of having an experiment go wrong, and dont be afraid to have a result that doesnt tell you anything, but learn from it. All data provides a lesson learn from it, keep adapting, evolving and trying again.

For Stephanie Carroll Lone, a science teacher at New Albany High School, Weatherholts influence was life-changing.

He had a way of making you want to do your very best, and she learned to love science, work hard and think in his classes, she said. She took several upper-level science classes with him during her junior and senior years before graduating from Floyd Central in 1995.

Floyd Central was a great school with a lot of good, challenging teachers, she said. Mr. Weatherholts class was one of the first that had really, really challenging upper-level thinking, and he motivated us to reach those high academic levels. He was so excited and passionate about the subject matter, and he got us excited too.

He didnt put stickers on tests unless students received a 100%, Lone said, so when she received a sticker, it was something special, and she felt a sense of achievement.

After she got married, she moved down the street from Weatherholt. As she drove by his home, he often was outside in his garden, and they waved at each other.

When Lone ran into Weatherholt over the past few decades, he always remembered her and knew what she was up to, and he seemed proud that she had followed in his footsteps to become a science teacher, she said.

It inspires her to think of how many people Weatherholt has influenced over the years, including those who became doctors, nurses or teachers, she said.

If he inspired each of those people to be something, and each one of them changed someone elses life, just think of the trickle effect, Lone said.

Weatherholt was involved in the Sunnyside Master Gardeners program for about 20 years. Gina Anderson, Floyd County Purdue Extension Educator, has known him since she started in 2013. He was a mentor to many, and he will be greatly missed in the community, she said.

He brought a wealth of knowledge as a Master Gardeners volunteer, she said, and he loved sharing his knowledge with others. He is the reason the county has so many wooden houses for bluebirds because he led the construction of several thousand boxes for the birds to nest.

He encouraged other people to learn to really involve themselves in something and learn about it, Anderson said. He just brought new knowledge and new perspectives to others.

Joe Hinton, former Floyd Central basketball coach, said in a Facebook post that Weatherholt always had his back when things got tough, and they worked together when Weatherholt coached junior high basketball for him for five years.

Weatherholt loved his profession, Hinton said.

He was good at understanding the kids he taught, he said. He was particularly good with the kids who wanted more beyond the normal load of class work.

Alison Tower Reid, a 1998 Floyd Central grad, said her high school science classes with Weatherholt were harder than any college science classes she took, and Weatherholt inspired her passion for science and nature. She now works as a certified nurse and midwife in Jeffersonville and is pursuing a doctorate in nursing practice.

Weatherholt wouldnt let students do the bare minimum in his class they had to put in an effort and actually learn to make it through the class, she said.

Reid recalls Weatherholts tradition of peeling oranges on test days so the smell could create a sense of calm for students it has always stuck with her, and now, every time she smells an orange peel, she will think of her former teacher, she said.

I will forever see him as a giant teddy bear with a big smile, she said. He was kind of quiet and reserved, and he always had a big smile for students. He was just a happy and gregarious kind of person.

Original post:
Community remembers longtime Floyd Central teacher Ray Weatherholt - Evening News and Tribune

Read More...

Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions…

Tuesday, September 15th, 2020

EpiPanelDxPLUS adds to Lineagens expanding menu of diagnostic tests for children with developmental disorders and provides an offering designed specifically for patients that have experienced seizures or other epilepsy-related symptoms

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the release of EpiPanelDxPLUS by its diagnostics services business, Lineagen. The new laboratory developed test (LDT) and associated clinical support bolsters Lineagens diagnostic services for physicians providing care for pediatric patients with neurodevelopmental disorders (NDDs). EpiPanelDxPLUS is based on a proprietary panel of 223 genes associated with epilepsy-related conditions, more genes than typically found on epilepsy panels available from other service providers and customized for Lineagens core market of neurodevelopmental disorders.

Epilepsy refers to an array of neurological disorders characterized by involuntary seizures and affects approximately 1.2% of the population, or 3.4 million people, in the United States. It is frequently comorbid with other NDDs of childhood development, including intellectual disability and autism spectrum disorder and also can co-occur with neuro-behavioral disorders such as attention deficit hyperactivity disorder (ADHD). Collectively, NDDs represent the most common form of developmental disorder with an estimated prevalence of 1 out of 6 children affected in industrialized countries. Lineagens current menu of FirstStepDx PLUS chromosomal microarray and NextStepDx PLUSwhole exome sequencing offers leading molecular diagnostic tests designed to help pediatricians and pediatric neurodevelopmental specialists manage their patients with NDDs. Offering such physicians a test for epilepsy allows Lineagen to more comprehensively serve their needs.

Identifying the underlying genetic variants that may explain the underlying cause of seizures is extremely important because it informs multiple aspects of clinical care, said Alka Chaubey, PhD, Chief Medical Officer of Bionano Genomics. This test allows for personalized treatment of the patient, can predict the recurrence risk for other members of the family, and ends the diagnostic odyssey, which for many families can mean years of doctor visits, invasive tests, and failed or even harmful treatments.

EpiPanelDxPLUS is designed for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures, and has an expected 30% diagnostic yield. Lineagen also offers testing to the parents of the patients. By including the analysis of the genomes of one or both biological parents of the patient from the start, it is possible to increase the detection rate of disease-causing variants and inform on recurrence risk for the family. EpiPanelDxPLUS has been curated based on thorough literature review and includes genes with pathogenic variants identified in more than 2,000 epileptic patients tested by Lineagen.

The use of a targeted gene panel such as EpiPanelDxPLUS fits the testing strategy that is recommended by the American Academy of Neurology and complements existing genetic tests offered by Lineagen such as FirstStepDx PLUS chromosomal microarray and NextStepDx PLUS whole exome sequencing, which are recommended for patients who show a wider array of neurological symptoms. To help tailor medical management, Lineagen also offers pharmacogenomic testing which includes certain genes that are responsible for the metabolism of important anti-epileptic or anticonvulsant drugs prescribed for epilepsy.

We already have a depth of knowledge on epilepsy genetics, added Dr Chaubey. We recently tested a 3-year-old girl with muscle spasms and seizures, as well as her parents, and identified a mutation in the SLC2A1 gene. Based on these results, the doctor was able to treat the child with a simple ketogenic diet and over-the-counter supplementation. If she had instead been treated with barbiturates, at one time a standard treatment for epilepsy patients and now contraindicated in patients with this specific genetic condition, her seizures likely would have gotten worse. This case is one of many where results of a genetic test enabled the family and treating physician to significantly improve the quality of life of the child and family.

"Adding the EpiPanelDxPLUS test to Lineagens menu is a critical step forward in our plan for Lineagen to grow and continue supporting the physicians who rely on them," said Erik Holmlin, PhD, Chief Executive Officer of Bionano Genomics. "This test also forms the basis of how we envision incorporating the Saphyr system for comprehensive structural variation analysis into an improved diagnostic testing approach for epilepsy. In its current form, the EpiPanelDx test uses next generation sequencing (NGS) to identify single nucleotide variants and for evidence of gene deletion or duplication in 223 genes. Deletions and duplications are examples of structural variations (SVs) that NGS can detect with reasonable sensitivity, but otherwise, NGS is essentially blind to certain SVs that Saphyr detects with ease. We believe using Saphyr in conjunction with NGS can enable later generations of EpiPanelDxPLUS to have potentially higher diagnostic yields by identifying more genetic variations, which may in turn diagnose more patients, and be a unique combination in the industry.

The EpiPanelDxPLUS diagnostic test is available now with full clinical support including genetic counselling. More details on the diagnostic test are available at https://lineagen.com/epipanel/

About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionanos Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visitwww.bionanogenomics.com or http://www.lineagen.com.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as may, will, expect, plan, anticipate, estimate, intend and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, intended use of Lineagens tests, including NextStepDX, anticipated benefits of expanded test offerings from Lineagen, anticipated improvements in patient treatment and diagnosis attributable to Lineagens tests, potential combinations or other uses of the Saphyr system in conjunction with Lineagens tests and any improvements in diagnostic testing generated from such uses. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of the COVID-19 pandemic on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive products; failure of our products to achieve the stated objectives or anticipated benefits; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the loss of key members of management and our commercial team; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2019 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACTSCompany Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858) 888-7610eholmlin@bionanogenomics.com

Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLC+1 (617) 430-7577arr@lifesciadvisors.com

Media Contact:Darren Opland, PhD+1 (617) 733-7668darren@lifescicomms.com

Follow this link:
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen's EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions...

Read More...

SIU researchers receive grant to study COVID-19 genome, track it through population – SIU News

Tuesday, September 15th, 2020

Koushik Sinha assistant professor of computer science in SIU Carbondales School of Computing, left, and Keith Gagnon, associate professor of chemistry and biochemistry in the College of Agricultural, Life and Physical Sciences, have received a one-year grant from the Walder Foundation aimed at better understanding and tracking the COVID-19 virus as it moves through populations. SIU will receive about $360,000 of the $500,000 grant, which involves sequencing the virus genomes and using analytic tools to track it. (Photo by Yenitza Melgoza)

September 14, 2020

by Tim Crosby

CARBONDALE, Ill. Although COVID-19 is probably 2020s most common term, many wrongly believe it refers to a specific bug that causes myriad symptoms ranging from fairly mild to deadly.

Researchers know the term actually encompasses a constantly evolving and varying virus that changes as it moves through populations over time. Understanding those changes can tell scientists many things, from its origins to the way it spreads to what it might do next, and unlocking those secrets using genetics and tracking technology is the goal of two researchers at Southern Illinois University Carbondale.

SIU leading the way

Keith Gagnon, associate professor of chemistry and biochemistry in SIUs College of Agricultural, Life and Physical Sciences, and Koushik Sinha, assistant professor of computer science in the School of Computing, have received a grant from the Walder Foundation. The SIU researchers will work with other scientists from the Open Commons Consortium in Chicago on the one-year, $500,000 project aimed at improving our understanding of the virus, with SIU receiving about $360,000 of the money.

Under the grant, the Illinois Department of Public Health will supply Gagnons lab with COVID-19 samples from patients mostly located in the Chicago area. Gagnons team will then sequence the virus genomes, and perform evolutionary and phylogenetic analyses on the genome sequences.

Combining data with technology

Gagnon said his lab will sequence the genome of SARS-CoV-2 viruses, which cause COVID-19, from positive patient samples. The study will sequence 5,000 virus genomes over the course of the project.

The genomic and analytic tools we will use should help us understand how the virus is moving and changing over time in the Chicago area by identifying variants of the virus, Gagnon said. We expect to identify the original founder outbreaks of the virus, such as geographic location in the world, and predict when different variants were introduced into the Chicago area.

The lab will sequence and analyze the genomes within two weeks of a positive case, Gagnon said. Combing that information with Google mobility data as practiced by Sinha and his team will reveal the demographics to understand how the virus is affecting certain populations, allowing authorities to make rapid decisions about public health policies.

Bringing analytic tools to the fight

Sinhas team will combine the mutation signatures of each virus, as well as where and when the sample was taken, with powerful analytical tools and map-view visualizations, rapidly sharing results with IDPH and other researchers and making them publicly available for viewing and downloading.

Mapping the diversity of mutations that the virus acquires will provide critical insight into better vaccine development, Gagnon said. And our tools can be used to evaluate the success of future vaccines as they are deployed.

Sinha said the goal is to create a one-stop-shop data and analytics infrastructure for storing, integrating, analyzing, and visualizing multiple types of epidemiological data. His group will create a custom visualization and data-analytics platform called COVID-19 Data Map (CoVD-Map). The platform will be an offshoot of the platform that he began developing in spring during some of the early, uncertain months of the pandemic.

Leveraging outside agencies

The teams CoVD-Map will be integrated with the Chicago CAN Commons and designed to work with other public-health surveillance systems, such as Illinoiss National Electronic Disease Surveillance System and the National Notifiable Diseases Surveillance System.

It will be unique in its ability to not only integrate diverse data sources through built-in analytics solutions, but also enable researchers to plug-in their own analytics tools and visualize their results using its visualization framework, Sinha said.

For instance, one analytic tool will be genomic epidemiology predictions of virus movement and change. The platform also will also integrate with other tools to present results in an intuitive, unified and timely manner, Sinha said.

Information enlightens approaches

The results, incorporating additional dimensions of data, will be accessible to government and health officials, researchers, and the public, he said. Healthcare and government officials can use the CoVD-Map to improve situational awareness and formulate responses while researchers can plug-in their own prediction models. Individuals might use it to understand how the pandemic is impacting their area and accordingly change their daily activity patterns.

The advances the teams hope to make might eventually be applied to other theaters and populations

We hope to expand this study to the broader state of Illinois to look at rural counties, as well, over time, said Gagnon, who also holds and appointment as an associate professor of biochemistry and molecular biology at the SIU School of Medicine.

Continued here:
SIU researchers receive grant to study COVID-19 genome, track it through population - SIU News

Read More...

Gestational Diabetes Linked to Accelerated Aging in Offspring – Endocrinology Network

Tuesday, September 15th, 2020

New data by a team of researchers at Rutgers University is shedding light on a potential connection between gestational diabetes and biological age of offspring.

An analysis including more than 1100 children from Tianjin, China, researchers revealed children born to mothers with gestational diabetes mellitus had a higher epigenetic age than their counterparts born to mothers without gestational diabetes mellitus. Additionally, this increased epigenetic age was linked to increased risk of other comorbidities later in life, such as obesity and increased blood pressure.

"These findings suggest that gestational diabetes may have long-term effects on epigenetic aging in offspring and lead to poorer cardiometabolic health outcomes," said lead author Stephanie Shiau, an instructor at the Rutgers School of Public Health, in a statement.

In an effort to further investigate the effects of gestational diabetes mellitus on offspring, Shiau and a team of colleagues from the US and China designed the current study. To do so, they designed their study as an analysis of estimated DNA methylation (DNAm) age in offspring born to mothers with and without gestational diabetes mellitus from the Tianjin GDM Observational Study.

Of note, the Tianjin GDM Observational Study was conducted between 2005-2009 and sought to compare risks of early postpartum diabetes and prediabetes in Chinese women with and without gestational diabetes mellitus during pregnancy. Ultimately, the trial contained cohorts of 1263 women with a history of gestational diabetes mellitus and 705 women without gestational diabetes mellitus. With a mean follow-up time of 3.53 years postpartum, Shiau and team used this study to identify data related to 1156 children between the ages of 3-10 years born to mothers within the study.

Of the 1156 children included, 758 were born to mothers with gestational diabetes and 758 were born to mothers without gestational diabetes. All children included in the study underwent an exam at a median age of 5.9 years (3.1-10.2) that included anthropometric measurements and a blood draw for DNAm analysis. For the purpose of analysis, DNAm age was calculated using Horvath and Hannum epigenetic clock algorithms and the residual resulting from regressing DNAm age on chronological age was used as the metric for age acceleration.

Upon analysis, results indicated chronological age strongly correlated with both the Horvath DNAm age (r=.53; P <.0001) and the Hannum DNAm age (r=.38; P <.0001). Results also indicated offspring age acceleration was higher among those born to mothers with gestational diabetes mellitus compared to their counterparts who had mother without gestational diabetes mellitus when adjusting for potential confounders (Horvath, 4.96 months higher, P=.0002; Hannum, 11.2 months higher, P <.0001). Investigators noted the Horvath algorith was adjusted for sex, pre-pregnancy BMI, cell-type proportions, and technical bias while the Hannum algorithm adjusted for cell-type proportions and technical bias.

Results of the analyses suggest increased offspring DNAm age acceleration was associated with increased offspring weight-for-age Z-score, BMI-for-age-Z-score, waist circumference, body fat percentage, subscapular skinfold, suprailiac skinfold, upper-arm circumference, and blood pressure. Investigators pointed out these associations were strong among offspring born to mothers with gestational diabetes mellitus.

We found that offspring of women with gestational diabetes mellitus exhibit accelerated epigenetic age compared to control participants, independent of other maternal factors. Epigenetic age in offspring was associated with cardiometabolic risk factors, suggesting that gestational diabetes mellitus and gestational diabetes mellitus-associated factors may have long-term effects on offspring epigenetic age and contribute to health outcomes, wrote investigators.

This study, Prenatal gestational diabetes mellitus exposure and accelerated offspring DNA methylation age in early childhood, was published in Epigenetics.

Originally posted here:
Gestational Diabetes Linked to Accelerated Aging in Offspring - Endocrinology Network

Read More...

What patients on dialysis need to know about controlling diabetes – The Indian Express

Tuesday, September 15th, 2020

By: Lifestyle Desk | New Delhi | September 15, 2020 6:20:26 pm'As one of the most noteworthy causes of CKD, the rise in the number of diabetic patients in India directly correlates with the increase in the number of kidney disease patients.' (Representational image)

Many people around the world live with diabetes either type 1 or type 2 and the condition calls for many lifestyle changes for them to lead a normal and healthy life. Dr Nishit Mohanty, Nephrologist, NephroPlus Dialysis Centers, Bhubaneswar & Balasore, says the number of people in India crippled with Chronic Kidney Diseases (CKD) associated with diabetes, is high.

As one of the most noteworthy causes of CKD, the rise in the number of diabetic patients in India directly correlates with the increase in the number of kidney disease patients. In the times of COVID-19, both co-morbidities are a major risk concern and should be taken into serious consideration, he warns.

The doctor goes on to say that while one is on dialysis, it is important to take care of diabetes. As a result of diabetes, the blood vessels in the kidneys weaken and become damaged. Damaged blood vessels limit the kidneys to work as well as they should, that is, to filter out the toxins and waste from the body. A decline in kidney function may eventually cause kidney failure.

Maintaining and being vigilant of blood sugar levels, consuming a well-balanced diet and exercising are key factors in controlling diabetes, he says.

ALSO READ |A pandemic is never absolutely over, but it can be controlled: Dr Naresh Trehan

Here are some dietary tips from the doctor:

* Eat as per the nutrition plan curated by your nephrologist and dietician.* Eating three meals a day which is a must will help in preventing the blood sugar from going too high or too low.* High-caloric food must be avoided.* Non- processed foods such fresh vegetables and fruits, grains, lean meats and low-fat dairy options should be ideal for nutritious diet.* Foods low in potassium will add fiber to your diet.* Keep your liquid consumption in check, as advised.

Physical activities:

* Exercise daily to maintain a healthy weight; do not over-stress yourself.* Obesity should be looked at with utmost care; reduce if overweight.* Include aerobic and resistance training which will help in lowering blood sugar and keep blood glucose within a normal range.* Practising yoga will help calm the mind and body.

ALSO READ |How do COVID-19 triggered blood clots affect the heart? A doctor answers

Medication:

* Monitor your blood sugar regularly.* Medication must be taken as prescribed by your doctor.* Maintain good eye care; have your eyes checked if you experience any discomfort.* It is also important to maintain good oral hygiene. Brush your teeth in the morning and at night; gargle your mouth after meals.* Blood glucose should be monitored well on dialysis days, mainly before you begin your dialysis treatment.

For more lifestyle news, follow us: Twitter:lifestyle_ie|Facebook:IE Lifestyle| Instagram:ie_lifestyle

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Lifestyle News, download Indian Express App.

IE Online Media Services Pvt Ltd

See the original post:
What patients on dialysis need to know about controlling diabetes - The Indian Express

Read More...

Page 20«..10..19202122..3040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick